Advertisement
Advertisement

INDV

INDV logo

Indivior Pharmaceuticals, Inc. Common Stock

39.08
USD
Sponsored
+0.07
+0.18%
Aug 17, 15:59 UTC -4
Closed
exchange

After-Market

39.37

+0.29
+0.73%

Indivior Pharmaceuticals, Inc. Common Stock Profile

About

Indivior Pharmaceuticals Inc., together with its subsidiaries, develops, manufactures and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders principally in the United States, Europe, Canada, Australia and internationally. Indivior Pharmaceuticals Inc., formerly known as Indivior PLC., is based in Chesterfield, Virginia.

Info & Links

CEO

Joseph Ciaffoni

Headquarters

10710 Midlothian Turnpike Suite 125
North Chesterfield, VA 23235, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.indivior.com

Auditor

PricewaterhouseCoopers LLP

Share holders

139

Employees

838

Indivior Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.65B

Enterprise Value

4.91B

Enterprise Value/EBITDA(ttm)

11.24

Price to Earnings Ratio(ttm)

10.69

Price to Sales(ttm)

3.46

Price to Book(mrq)

--

Price to Cash(ytd)

14.34

Profitability

Gross Margin(ttm)

82.10%

Operating Margin(ttm)

34.91%

Profit Margin(ttm)

26.47%

Return on Equity(ttm)

-283.11%

Return on Invested Capital(ttm)

166.70%

Return on Assets(ttm)

36.85%

Income Statement

Revenue(ttm)

1.33B

Revenue Per Share(ttm)

--

Gross Profit(ttm)

1.09B

EBITDA(ttm)3

437.00M

Net Income Available to Common(ttm)

356.00M

Diluted EPS(ttm)

2.79

Share Statistics

Beta (5Y Monthly)

0.86

52-Week Change

66.58%

S&P 500 52-Week Change

20.09%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

117.14M

% Held by Insiders

0.74%

% Held by Institutions

60.33%

Balance Sheet

Total Cash(mrq)

222.00M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

487.00M

Total Debt/Equity(mrq)

-234.13%

Current Ratio(mrq)

0.84%

Quick Ratio(mrq)

0.66%

Book Value Per Share(mrq)

-1.76

Cash Flow

Operating Cash Flow Per Share(ytd)

1.77

Free Cash Flow(ytd)

193.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement